Dare Bioscience (DARE) Competitors $2.24 -0.01 (-0.44%) Closing price 04:00 PM EasternExtended Trading$2.24 0.00 (0.00%) As of 07:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock DARE vs. ANIX, ZNTL, ATOS, MGNX, STTK, IRD, VTGN, ANRO, SPRO, and VIRIShould you be buying Dare Bioscience stock or one of its competitors? The main competitors of Dare Bioscience include Anixa Biosciences (ANIX), Zentalis Pharmaceuticals (ZNTL), Atossa Genetics (ATOS), MacroGenics (MGNX), Shattuck Labs (STTK), Opus Genetics (IRD), VistaGen Therapeutics (VTGN), Alto Neuroscience (ANRO), Spero Therapeutics (SPRO), and Virios Therapeutics (VIRI). These companies are all part of the "pharmaceutical products" industry. Dare Bioscience vs. Its Competitors Anixa Biosciences Zentalis Pharmaceuticals Atossa Genetics MacroGenics Shattuck Labs Opus Genetics VistaGen Therapeutics Alto Neuroscience Spero Therapeutics Virios Therapeutics Dare Bioscience (NASDAQ:DARE) and Anixa Biosciences (NASDAQ:ANIX) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, dividends, analyst recommendations, profitability, valuation, risk and media sentiment. Do institutionals & insiders believe in DARE or ANIX? 6.7% of Dare Bioscience shares are owned by institutional investors. Comparatively, 29.1% of Anixa Biosciences shares are owned by institutional investors. 4.8% of Dare Bioscience shares are owned by company insiders. Comparatively, 25.3% of Anixa Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the media prefer DARE or ANIX? In the previous week, Anixa Biosciences had 1 more articles in the media than Dare Bioscience. MarketBeat recorded 3 mentions for Anixa Biosciences and 2 mentions for Dare Bioscience. Dare Bioscience's average media sentiment score of 1.23 beat Anixa Biosciences' score of 0.20 indicating that Dare Bioscience is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Dare Bioscience 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Anixa Biosciences 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has higher valuation and earnings, DARE or ANIX? Dare Bioscience has higher revenue and earnings than Anixa Biosciences. Anixa Biosciences is trading at a lower price-to-earnings ratio than Dare Bioscience, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDare Bioscience$10K3,019.52-$4.05M-$2.14-1.05Anixa BiosciencesN/AN/A-$12.55M-$0.35-11.74 Is DARE or ANIX more profitable? Dare Bioscience's return on equity of 0.00% beat Anixa Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Dare BioscienceN/A N/A -103.70% Anixa Biosciences N/A -67.45%-59.18% Which has more volatility and risk, DARE or ANIX? Dare Bioscience has a beta of 1.14, meaning that its share price is 14% more volatile than the S&P 500. Comparatively, Anixa Biosciences has a beta of 0.69, meaning that its share price is 31% less volatile than the S&P 500. Do analysts prefer DARE or ANIX? Dare Bioscience currently has a consensus target price of $10.00, indicating a potential upside of 346.43%. Anixa Biosciences has a consensus target price of $9.00, indicating a potential upside of 118.98%. Given Dare Bioscience's higher possible upside, analysts plainly believe Dare Bioscience is more favorable than Anixa Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Dare Bioscience 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33Anixa Biosciences 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 SummaryDare Bioscience and Anixa Biosciences tied by winning 7 of the 14 factors compared between the two stocks. Get Dare Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for DARE and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DARE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DARE vs. The Competition Export to ExcelMetricDare BioscienceMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$30.20M$3.32B$6.10B$10.53BDividend YieldN/A2.29%5.51%4.66%P/E Ratio-1.0521.5485.6826.85Price / Sales3,019.52428.14584.82185.94Price / CashN/A46.3226.3031.10Price / Book-3.2510.0613.256.72Net Income-$4.05M-$52.22M$3.30B$276.44M7 Day Performance6.67%5.84%4.70%3.13%1 Month Performance4.19%12.05%8.43%10.21%1 Year Performance-32.12%26.13%88.01%40.35% Dare Bioscience Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DAREDare Bioscience1.9583 of 5 stars$2.24-0.4%$10.00+346.4%-30.3%$30.20M$10K-1.0530News CoverageANIXAnixa Biosciences2.6217 of 5 stars$3.41+0.3%$9.00+163.9%+3.2%$111.92M$210K-9.745News CoverageAnalyst ForecastGap UpZNTLZentalis Pharmaceuticals1.4551 of 5 stars$1.49-3.9%$5.84+291.9%-52.8%$111.81M$67.43M-0.66160Positive NewsATOSAtossa Genetics2.1926 of 5 stars$0.87+1.7%$6.25+616.2%-32.0%$110.89MN/A-3.798News CoverageMGNXMacroGenics4.5048 of 5 stars$1.75+1.2%$3.60+105.7%-51.0%$109.35M$163.87M-3.07430Positive NewsSTTKShattuck Labs3.8725 of 5 stars$2.27-0.4%$4.00+76.2%+112.3%$109.22M$5.72M-1.88100Positive NewsIRDOpus Genetics2.2519 of 5 stars$1.79-1.6%$7.33+309.7%N/A$109.03M$10.99M-0.9314Positive NewsShort Interest ↑VTGNVistaGen Therapeutics0.6083 of 5 stars$3.54+0.3%N/A+29.2%$108.30M$490K-1.9940Gap UpANROAlto Neuroscience2.2419 of 5 stars$4.04+2.2%$9.80+142.9%-37.3%$106.95MN/A-1.69N/ASPROSpero Therapeutics4.2515 of 5 stars$1.90+0.5%$5.00+163.2%+60.8%$106.36M$47.98M-1.94150News CoveragePositive NewsVIRIVirios TherapeuticsN/A$5.52+8.0%$5.00-9.4%+3,688.4%$106.30MN/A-20.445Gap Down Related Companies and Tools Related Companies Anixa Biosciences Alternatives Zentalis Pharmaceuticals Alternatives Atossa Genetics Alternatives MacroGenics Alternatives Shattuck Labs Alternatives Opus Genetics Alternatives VistaGen Therapeutics Alternatives Alto Neuroscience Alternatives Spero Therapeutics Alternatives Virios Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DARE) was last updated on 10/7/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dare Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dare Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
